On the public citation graph

Levodopa and dopamine dynamics in Parkinson’s disease metabolomics

https://doi.org/10.1101/306266
0 signed · 61 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/0471250953openalex-snapshot
Current Protocols in Bioinformatics
inferredcites →https://doi.org/10.1002/0471250953.bi0112s38openalex-snapshot
Using the KEGG Database Resource
inferredcites →https://doi.org/10.1002/cpbi.11openalex-snapshot
Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis
inferredcites →https://doi.org/10.1002/mds.20844openalex-snapshot
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
inferredcites →https://doi.org/10.1002/mds.21198openalex-snapshot
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan
inferredcites →https://doi.org/10.1007/bf00308809openalex-snapshot
Neuropathological stageing of Alzheimer-related changes
inferredcites →https://doi.org/10.1007/bf01271257openalex-snapshot
Elevated levels of harman and norharman in cerebrospinal fluid of Parkinsonian patients
inferredcites →https://doi.org/10.1007/s11064-011-0437-yopenalex-snapshot
Mice Lacking Major Brain Gangliosides Develop Parkinsonism
inferredcites →https://doi.org/10.1007/s12035-017-0845-3openalex-snapshot
Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
inferredcites →https://doi.org/10.1016/0306-4522(93)90500-fopenalex-snapshot
Degeneration of purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline
inferredcites →https://doi.org/10.1016/1055-8330(95)90016-0openalex-snapshot
An endogenous dopaminergic neurotoxin: Implication for Parkinson's disease
inferredcites →https://doi.org/10.1016/j.biopsych.2009.01.027openalex-snapshot
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
inferredcites →https://doi.org/10.1016/j.jns.2015.06.028openalex-snapshot
GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding
inferredcites →https://doi.org/10.1016/j.parkreldis.2015.07.009openalex-snapshot
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration
inferredcites →https://doi.org/10.1016/s0006-8993(03)03354-7openalex-snapshot
3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson’s disease pathogenesis
inferredcites →https://doi.org/10.1016/s0006-8993(98)00538-1openalex-snapshot
Studies on the interaction between 1,2,3,4-tetrahydro-β-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease
inferredcites →https://doi.org/10.1016/s0140-6736(01)08875-4openalex-snapshot
HARMALOL IN THE TREATMENT OF PARKINSONISM.
inferredcites →https://doi.org/10.1016/s0168-0102(03)00097-xopenalex-snapshot
N-methylated β-carbolines protect PC12 cells from cytotoxic effect of MPP+ by attenuation of mitochondrial membrane permeability change
inferredcites →https://doi.org/10.1016/s0896-6273(03)00568-3openalex-snapshot
Parkinson's Disease
inferredcites →https://doi.org/10.1016/s1734-1140(10)70241-3openalex-snapshot
9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease
inferredcites →https://doi.org/10.1021/ac0713510openalex-snapshot
Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class Models
inferredcites →https://doi.org/10.1021/acs.chemrestox.6b00179openalex-snapshot
Computational Metabolomics: A Framework for the Million Metabolome
inferredcites →https://doi.org/10.1021/bi061749aopenalex-snapshot
GM1 Specifically Interacts with α-Synuclein and Inhibits Fibrillation
inferredcites →https://doi.org/10.1021/pr301053dopenalex-snapshot
Hybrid Feature Detection and Information Accumulation Using High-Resolution LC–MS Metabolomics Data
inferredcites →https://doi.org/10.1021/pr500807topenalex-snapshot
LC–MS-Based Urinary Metabolite Signatures in Idiopathic Parkinson’s Disease
inferredcites →https://doi.org/10.1038/srep13888openalex-snapshot
Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson’s disease
inferredcites →https://doi.org/10.1046/j.0953-816x.2001.01563.xopenalex-snapshot
Protective effect of harmaline and harmalol against dopamine‐ and 6‐hydroxydopamine‐induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells
inferredcites →https://doi.org/10.1046/j.1471-4159.1994.62041503.xopenalex-snapshot
Differential Cytotoxicities of N‐Methyl‐β‐Carbolinium Analogues of MPP+ in PC12 Cells: Insights into Potential Neurotoxicants in Parkinson's Disease
inferredcites →https://doi.org/10.1073/pnas.1616892114openalex-snapshot
Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease
inferredcites →https://doi.org/10.1074/jbc.275.4.2455openalex-snapshot
β-Carbolines That Accumulate in Human Tissues May Serve a Protective Role against Oxidative Stress
inferredcites →https://doi.org/10.1093/brain/awm304openalex-snapshot
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
inferredcites →https://doi.org/10.1093/nar/gks1065openalex-snapshot
HMDB 3.0—The Human Metabolome Database in 2013
inferredcites →https://doi.org/10.1097/jom.0000000000000772openalex-snapshot
Pilot Metabolome-Wide Association Study of Benzo(a)pyrene in Serum From Military Personnel
inferredcites →https://doi.org/10.1101/gr.1239303openalex-snapshot
Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks
inferredcites →https://doi.org/10.1111/j.1471-4159.2004.02397.xopenalex-snapshot
Dopamine transporter‐mediated cytotoxicity of β‐carbolinium derivatives related to Parkinson's disease: relationship to transporter‐dependent uptake
inferredcites →https://doi.org/10.1111/j.1471-4159.2010.06725.xopenalex-snapshot
The exceptional properties of 9‐methyl‐β‐carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti‐inflammatory effects
inferredcites →https://doi.org/10.1111/j.1532-5415.2005.53221.xopenalex-snapshot
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
inferredcites →https://doi.org/10.1111/jnc.12345openalex-snapshot
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease
inferredcites →https://doi.org/10.1124/pr.56.3.1openalex-snapshot
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
inferredcites →https://doi.org/10.1136/jnnp-2014-309676openalex-snapshot
Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
inferredcites →https://doi.org/10.1186/1423-0127-16-63openalex-snapshot
Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection
inferredcites →https://doi.org/10.1186/1471-2105-14-15openalex-snapshot
xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data
inferredcites →https://doi.org/10.1186/1471-2164-7-142openalex-snapshot
Centering, scaling, and transformations: improving the biological information content of metabolomics data
inferredcites →https://doi.org/10.1212/wnl.45.12.2240openalex-snapshot
beta-Carbolinium cations, endogenous MPP plus analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease
inferredcites →https://doi.org/10.1212/wnl.51.1.2openalex-snapshot
Changes and new features in Neurology
inferredcites →https://doi.org/10.1371/journal.pcbi.1003123openalex-snapshot
Predicting Network Activity from High Throughput Metabolomics
inferredcites →https://doi.org/10.1371/journal.pone.0007551openalex-snapshot
Metabolomic Profiling in LRRK2-Related Parkinson's Disease
inferredcites →https://doi.org/10.1371/journal.pone.0015251openalex-snapshot
The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis
inferredcites →https://doi.org/10.1371/journal.pone.0077629openalex-snapshot
Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson’s Disease: a Pilot Study
inferredcites →https://doi.org/10.1515/bmc-2013-0039openalex-snapshot
GM1 and GM2 gangliosides: recent developments
inferredcites →https://doi.org/10.1523/jneurosci.5456-13.2014openalex-snapshot
Is Parkinson's Disease a Vesicular Dopamine Storage Disorder? Evidence from a Study in Isolated Synaptic Vesicles of Human and Nonhuman Primate Striatum
inferredcites →https://doi.org/10.1586/14737159.8.5.617openalex-snapshot
Metabolomics-based methods for early disease diagnostics
inferredcites →https://doi.org/10.3233/jpd-140389openalex-snapshot
Metabolite and Peptide Levels in Plasma and CSF Differentiating Healthy Controls from Patients with Newly Diagnosed Parkinson’s Disease
inferredcites →https://doi.org/10.3233/jpd-179004openalex-snapshot
L-DOPA
inferredcites →https://doi.org/10.3389/fbioe.2015.00023openalex-snapshot
Analytical Methods in Untargeted Metabolomics: State of the Art in 2015
inferredcites →https://doi.org/10.3390/metabo2040775openalex-snapshot
A Guideline to Univariate Statistical Analysis for LC/MS-Based Untargeted Metabolomics-Derived Data
inferredcites →https://doi.org/10.3988/jcn.2005.1.1.81openalex-snapshot
Comparison of the Protective Effect of Indole β-carbolines and R-(-)-deprenyl Against Nitrogen Species-Induced Cell Death in Experimental Culture Model of Parkinson's Disease
inferredcites →https://doi.org/10.4103/0973-7847.120524openalex-snapshot
Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids
inferredcites →https://doi.org/10.5402/2012/506160openalex-snapshot
Ganglioside Biochemistry

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1093/nutrit/nuaf232openalex-snapshot
Pantothenic Acid and Parkinson Disease: A Systematic Review of Metabolomics Analysis Studies
inferred← citeshttps://doi.org/10.18097/pbmcr1642openalex-snapshot
The effect of levodopa on the blood antioxidant system and metabolome in patients with Parkinson's disease
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.